Cytomegalovirus‐specific T‐cell immunity and DNAemia in patients with chronic lymphocytic leukaemia undergoing treatment with ibrutinib

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2021-11, Vol.195 (4), p.637-641
Hauptverfasser:	Solano de la Asunción, Carlos, Terol, María José, Saus, Ana, Olea, Beatriz, Giménez, Estela, Albert, Eliseo, López‐Jiménez, Javier, Andreu, Rafael, García, Dolores, Fox, Laura, Remigia, María José, Amat, Paula, Solano, Carlos, Navarro, David
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenine - analogs & derivatives Adenine - therapeutic use Aged Aged, 80 and over CD4-Positive T-Lymphocytes - immunology CD8-Positive T-Lymphocytes - immunology chronic lymphocytic leukaemia Chronic lymphocytic leukemia CMV CMV CD4+ T cells CMV CD8+ T cells CMV DNAemia Cytomegalovirus Cytomegalovirus - genetics Cytomegalovirus - immunology Cytomegalovirus Infections - blood Cytomegalovirus Infections - complications Cytomegalovirus Infections - immunology DNA, Viral - blood Female Humans ibrutinib Interferon-gamma Release Tests Leukemia, Lymphocytic, Chronic, B-Cell - blood Leukemia, Lymphocytic, Chronic, B-Cell - complications Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Leukemia, Lymphocytic, Chronic, B-Cell - immunology Male Middle Aged Piperidines - therapeutic use Protein Kinase Inhibitors - therapeutic use T-Cell Antigen Receptor Specificity T-Lymphocyte Subsets - immunology Viral Matrix Proteins - blood Viremia - complications Viremia - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!